Optimizing the clinical use of implantable defibrillators in patients with Brugada syndrome

European Heart Journal, Supplement

Volumn 9, Issue I, 2007, Pages

  Sarkozy, Andrea ^a   Brugada, Pedro ^a   Mont, Lluis ^b   Brugada, Josep ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Brugada syndrome; Implantable cardioverter defibrillator; Ventricular tachyarrhythmias

Indexed keywords

EID: 77949350877     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sum070     Document Type: Review

References (27)

1. Mirowski M, Mower MM, Reid RR.The automatic implantable defibrillator. Am Heart J 1980;100:1089-1092.
2. Gollob MH, Seger JJ. Current status of the implantable cardioverter defibrillators. Chest 2001;119:1210-1221.
3. Lavergne T, Daubert JC, Chauvin M, Dolla E, Kacet S, Leenhardt A, Mabo P, Ritter P, Sadoul N, Saoudi N, Henry C, Nitzsche R, Ripart A, Murgatroyd F. Preliminary clinical experience with the first dual chamber pacemaker defibrillator. Pacing Clin Electrophysiol 1997;20:182-188.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Eng J Med 2005;352:225-237.
5. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 1992;20:1391-1396.
6. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome. Report of the second consensus conference. Circulation 2005;111:659-670.
7. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jais P, Pasquie J, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clementy J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation 2006;114:2317-2324.
8. Sarkozy A, Boussy T, Kourgiannides G, Chierchia GB, Richter S, De Potter T, Geelen P, Wellens F, Spreeuwenberg, Brugada P. Long term follow up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome. Eur Heart J 2007;28:334-344.
9. Swerdlow CD, Russo AM, Degroot PJ. The dilemma of ICD implant testing. Pacing Clin Electrophysiol 2007;30:675-700.
10. Mainigi SK, Callans DJ. How to manage the patient with a high defibrillation threshold. Heart Rhythm 2006;3:492-495.
11. Watanabe H, Chinushi M, Sugiura H, Washizuka T, Komura S, Hosaka Y, Furushima H, Watanabe H, Hayashi J, Aizawa YJ. Unsuccessful internal defibrillation in Brugada syndrome: focus on refractoriness and ventricular fibrillation cycle length. J Cardiovasc Electrophysiol 2005;16:262-266.
12. Thammanomai A, Sweeney MO, Eisenberg SR. A comparison of the output characteristics of several implantable cardioverter-defibrillators. Heart rhythm 2006;3:1053-1059.
13. Swerdlow CD. ICD waveforms: what really matters. Heart Rhythm 2006;3:1060-1062.
14. Mouchawar G, Kroll M, Val-mejias JE, Schwartzman D, Mckenzie J, Fitzgerald D, Prater S, Katcher M, Fain E, Syed Z. ICD waveform optimization: a randomized prospective pair-sampled multicenter study. Pacing Clin Electrophysiol 2000;23:1992-1995.
15. Kroll M, Efimov IR, Tchou PJ. Present understanding of shock polarity for internal defibrillation: The obvious and non-obvious clinical implications. Pacing Clin Electrophysiol 2006;29:885-891.
16. Bordachar P, Reuter S, Garrigue S, Cai X, Hocini M, Jais P, Haissaguerre M, Clementy J. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004;25:879-884.
17. Love BA, Barrett KS, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK, Walsh EP, Berul CI. Supraventricular arrhythmias in children and young adults with implantable cardioverter defibrillators. J Cardiovasc Electrophysiol 2001;12:1097-1101.
18. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S, Saggau W, Weisse U, Seidl K. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of 10 years. Circulation 2007;115:2474-2480.
19. Boriani G, Occhetta E, Pistis G, Menozzi C, Jofrida M, Sermasi S, Pagani M, Gasparini G, Musso G, Dall'Acqua A, Biffi M, Branzi A. Combined use of morphology discrimination, sudden onset and stability as discriminating algorithms in single chamber cardioverter defibrillators. Pacing Clin Electrophysiol 2002;25:1357-1366.
20. Klein GJ, Gillberg JM, Tang A, Inbar S, Sharma A, Unterberg-Buchwald C, Dorian P, Duru F, Rooney E, Becker D, Schaaf K, Benditt D. for the worldwide WAVE investigators. Improving SVT discrimination in single-chamber ICDs: a new electrogram morphology-based algorithm. J Cardiovasc Electrophysiol 2006;17:1310-1319.
21. Gold MR, Shorofsky SR, Thompson JA, Kim J, Schwartz M, Bocek J, Lovett EG, Hsu W, Morris MM, Lang DJ. Advanced rhythm discrimination for implantable cardioverter defibrillators using electrogram vector timing and correlation. J Cardiovasc Electrophysiol 2002;13:1092-1097.
22. Veltman C, Schimpf R, Echternach C, Eckardt L, Kuschyk J, Streitner F, Spehl S, Borggrefe M, Wolpert C. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification. Eur Heart J 2006;27:2544-2552.
23. Stix G, Della Bella P, Carbucicchio C, Schmidinger H. Spatial and temporal heterogeneity of depolarization and repolarization may complicate implantable cardioverter defibrillator therapy in Brugada syndrome. J Cardiovasc Electrophysiol 2000;11:516-521.
24. Sears SF, Burns JL, Handberg E, Sotile WM, Conti JB. Young at heart: understanding the unique psychosocial adjustment of young implantable cardioverter defibrillator recipients. Pacing Clin Electrophysiol 2001;24:1113-1117.
25. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 2002;105:589-594.
26. Gilliam FR. T-wave oversensing in implantable cardiac defibrillators is due to technical failure of device sensing. J Cardiovasc Electrophysiol 2006;17:553-556.
27. Lazarus A. Remote wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol 2007;30:S2-S12.